During the past decade, Capital Region Southwest Campus conducted 147 clinical trials. In the 10-year time frame, 147 clinical trials started and 63 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 42 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital Region Southwest Campus" #1 sponsor was "National Cancer Institute (NCI)" with 115 trials, followed by "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Region Southwest Campus" #1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Capital Region Southwest Campus" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Recurrent Ovarian Carcinoma" (7 trials). Many other conditions were trialed in "Capital Region Southwest Campus" in a lesser frequency.

Most popular intervention types in "Capital Region Southwest Campus" are "Drug" (161 trials), "Other" (134 trials), "Biological" (93 trials), "Procedure" (62 trials) and "Radiation" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (65 trials), "Quality-of-Life Assessment" (56 trials), "Questionnaire Administration" (39 trials), "Biospecimen Collection" (35 trials) and "Computed Tomography" (35 trials). Other intervention names were less common.

The vast majority of trials in "Capital Region Southwest Campus" are 173 trials for "All" genders, 30 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Capital Region Southwest Campus". undefined are not yet recruiting, 71 are recruiting, 104 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Capital Region Southwest Campus, 6 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Region Southwest Campus, 7 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 101 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".